Zonisamide as add-on treatment for children with epilepsy
Part of Brain & nervous system clinical trials.
This trial tests adding zonisamide to the current epilepsy medication for children aged 1 to 14 who still have focal seizures. The goal is to see if the combination works better and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 14 years old
- You have been taking one seizure medication for at least 4 weeks and it is not fully controlling your seizures
- You have had at least 2 seizures that start in one part of the brain and spread to both sides in a month
- You have not taken zonisamide before
- You are not allergic to sulfa drugs or zonisamide
- You do not have a history of serious mental health conditions or certain other illnesses
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a liquid form of the seizure medicine zonisamide in children aged 1 month to 17 years. It aims to see how the medicine works in the body and whether it is safe and well-tolerated for controlling partial-onset seizures.
This Phase 3 trial tests XEN1101 added to your current seizure medicines for people with primary generalized tonic-clonic seizures. It’s for seizures that have not fully stopped even after trying at least two appropriate medicines.
This study tests an investigational drug called JZP926 (a type of cannabinoid) to see if it can reduce the number of days with myoclonic seizures in people with juvenile myoclonic epilepsy. If you have this condition and are at least 10 years old, you might be able to join.
This trial tests an oral cannabidiol medicine (Epidiolex) for children whose seizures are not controlled by other treatments. It aims to see if adding this drug can reduce seizure frequency.
This trial tests XEN1101 compared with a placebo (inactive pill) in people with focal-onset seizures that haven’t been fully controlled despite trying at least two anti-seizure medicines. If you qualify, you may help researchers see whether the study drug reduces seizure frequency and improves control.
This trial provides access to cannabidiol (CBD), a marijuana-derived compound, for children with severe epilepsy that hasn't improved with standard medications. The goal is to see if CBD can help reduce seizures in this difficult-to-treat group.
Hear when a new Epilepsies, Partial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.